Is Galera Therapeutics Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: GRTX) stock is to Hold GRTX stock.
Out of 3 analysts, 0 (0%) are recommending GRTX as a Strong Buy, 0 (0%) are recommending GRTX as a Buy, 3 (100%) are recommending GRTX as a Hold, 0 (0%) are recommending GRTX as a Sell, and 0 (0%) are recommending GRTX as a Strong Sell.
What is GRTX's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: GRTX) forecast ROE is N/A, which is considered weak.
What is GRTX's Price Target?
According to 3 Wall Street analysts that have issued a 1 year GRTX price target, the average GRTX price target is $0.35, with the highest GRTX stock price forecast at $0.50 and the lowest GRTX stock price forecast at $0.25.
On average, Wall Street analysts predict that Galera Therapeutics's share price could reach $0.35 by Aug 29, 2024. The average Galera Therapeutics stock price prediction forecasts a potential upside of 91.26% from the current GRTX share price of $0.18.
What is GRTX's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: GRTX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.1%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.